Annals of Behavioral Medicine

, Volume 18, Issue 4, pp 255–263 | Cite as

Effect of stress on opioid-seeking behavior: Evidence from studies with rats

  • Yavin Shaham
Empirical Research

Abstract

Studies concerned with the relation between exposure to stress and the behavioral effects of opioid agonists in animal models of drug use are reviewed. These studies, which primarily utilized male rats, indicate that under certain conditions short-term mild stressors increase self-administration of opioid drugs and reinstate herein-seeking behavior following a drugfree period. On the other hand, there is evidence that long-term chronic inescapable stressors and severe acute stressors reduce the reinforcing effects of morphine as measured by a conditioned place preference procedure and decrease the behavioral effects of other positive reinforcers. The results of the studies reviewed suggest that stressors are important modulators of opioid-taking behavior, especially during drug-free periods. The implications of these findings to the understanding of the neurobiology of relapse to opioid-seeking behavior and for strategies for medication development to prevent relapse to heroin are discussed.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. (1).
    Johnson EO, Kamilaris TC, Chrousos GP, Gold PW: Mechanisms of stress: A dynamic overview of hormonal and behavioral homeostasis.Neuroscience Biobehavioral Review. 1992,16: 115–130.CrossRefGoogle Scholar
  2. (2).
    Alexander BK, Hadaway PF: Opiate addiction: The case of an adaptive orientation.Psychological Bulletin 1982,92:367–381.PubMedCrossRefGoogle Scholar
  3. (3).
    Shiffman S, Wills TA:Coping and Substance Abuse. Orlando, FL: Academic Press, 1985.Google Scholar
  4. (4).
    Hall SM, Havassy BE, Wassermann DA: Commitment to abstinence and acute stress in relapse to alcohol, opiates, and nicotine.Journal of Consulting and Clinical Psychology. 1990,58: 175–181.PubMedCrossRefGoogle Scholar
  5. (5).
    O'Doherty F, Davies BJ: Life events and addiction: A critical review.British Journal of Addiction. 1987,82:127–137.PubMedCrossRefGoogle Scholar
  6. (6).
    Piazza PV, Deminiere JM, Maccari S, et al: Individual vulnerability to drug-self-administration: Action of corticosterone on dopaminergic systems as possible pathophysiological mechanism. In Willner P, Scheel-Kruger J (eds),The Mesolimbic Dopaminergic System: From Motivation to Action. New York: John Wiley & Sons, 1991, 473–495.Google Scholar
  7. (7).
    Goeders NE, Guerin GF: Non-contingent electric shock facilitates the acquisition of intravenous cocaine self-administration in rats.Psychopharmacology. 1994,114:63–70.PubMedCrossRefGoogle Scholar
  8. (8).
    Ramzey NF, Van Ree M: Emotional but not physical stress enhances intravenous cocaine self-administration in drug naive rats.Brain Research. 1993,608:216–222.CrossRefGoogle Scholar
  9. (9).
    Miczek KA, Mutchler N: Activational effects of social stress on IV cocaine self-administration in rats.Psychopharmacology. 1996,128:256–264.PubMedCrossRefGoogle Scholar
  10. (10).
    Haney M, Maccari S, Le Moal M, Simon H, Piazza PV: Social stress increases the acquisition of cocaine self-administration behavior in male and female rats.Brain Research. 1995,698:46–52.PubMedCrossRefGoogle Scholar
  11. (11).
    Piazza PV, Le Moal M: Pathophysiological basis of vulnerability to drug abuse: Interaction between stress, glucocorticoids, and dopaminergic neurons.Annual Review Pharmacology and Toxicology. 1996,36:359–378.CrossRefGoogle Scholar
  12. (12).
    Pohorecky LA: Interaction of ethanol and stress: Research with experimental animals—An update.Alcohol and Alcoholism. 1990,25:263–276.PubMedGoogle Scholar
  13. (13).
    Baum A: Stress, intrusive imagery, and chronic distress.Health Psychology 1990,9:653–675.PubMedCrossRefGoogle Scholar
  14. (14).
    Cohen F, Horowitz MJ, Lazarus RS, et al: Panel report on psychosocial and modifiers of stress. In Eliott GR, Eisdorfer C (eds),Stress and Human Health. New York: Springer, 1982, 147–188.Google Scholar
  15. (15).
    Cohen S, Evans GW, Stokols D, Krantz DS:Behavior, Health, and Environmental Stress. New York: Plenum Press, 1986.Google Scholar
  16. (16).
    Glass DC, Singer JE:Urban Stress: Experiments on Noise and Social Stressors. New York: Academic Press 1972.Google Scholar
  17. (17).
    Weiss JM: Psychological factors in stress and disease.Scientific American. 1972,226:104–113.PubMedCrossRefGoogle Scholar
  18. (18).
    Selye H:The Stress of Life. New York: McGraw-Hill, 1956.Google Scholar
  19. (19).
    Mason JW: A historical view of the stress field: Part I.Journal of Human Stress 1975.1:6–12.PubMedGoogle Scholar
  20. (20).
    Kant GJ, Leu JR, Anderson SM, Mougey EH: Effects of chronic stress on plasma corticosterone, ACTH, and prolactin.Physiology and Behavior. 1987,40:775–779.PubMedCrossRefGoogle Scholar
  21. (21).
    Kvetnansky R, Mikulaj L: Adrenal and urinary catecholamines in rats during adaptation to repeated immobilization stress.Endocrinology. 1970,87:738–743.PubMedGoogle Scholar
  22. (22).
    Nisenbaum LK, Zigmond MJ, Sved AF, Abercombie ED: Prior exposure to chronic stress results in enhanced synthesis and release of hippocampal norepinephrine in response to a novel stressor.Journal of Neuroscience 1991,11:1478–1484.PubMedGoogle Scholar
  23. (23).
    Stewart J, Badiani A: Tolerance and sensitization to the behavioral effects of drugs.Behavioral Pharmacology 1993,4:289–312.Google Scholar
  24. (24).
    Amit A, Galina H: Stress-induced analgesia: Adaptive pain suppression.Physiological Reviews. 1986,66:1091–1120.PubMedGoogle Scholar
  25. (25).
    Kalivas PW, Stewart J: Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity.Brain Research Reviews 1991,16:223–244.PubMedCrossRefGoogle Scholar
  26. (26).
    Catania CA:Learning. Englewood Cliffs, NJ: Prentice-Hall, 1992.Google Scholar
  27. (27).
    Johanson CE, Woolverton WL, Schuster CR: Evaluating laboratory models of drug dependence. In Meltzer HY (ed),Psychopharmacology: The Third Generation of Progress. New York: Raven Press, 1987, 1617–1626.Google Scholar
  28. (28).
    Brady JV: Animal models for assessing drugs of abuse.Neuroscience Biobehavioral Review. 1991,15:35–43.CrossRefGoogle Scholar
  29. (29).
    Yokel RA: Intravenous self-administration: Response rates, the effects of pharmacological challenges, and drug preference. In Bozarth MA (ed),Methods of Assessing the Reinforcing Properties of Abused Drugs. New York: Springer-Verlag, 1987, 1–34.Google Scholar
  30. (30).
    Phillips AG, Fibiger HC: Anatomical and neurochemical substrates of drug reward determined by the conditioned place preference technique. In Bozarth MA (ed),Methods of Assessing the Reinforcing Properties of Abused Drugs. New York: Springer-Verlag 1987, 275–290.Google Scholar
  31. (31).
    Wise RA: The brain and reward. In Liebman JM, Kooper SJ (eds),The Neuropharmacological Basis of Reward. Oxford, England: Oxford University Press, 1989, 377–424.Google Scholar
  32. (32).
    Pavlov IP:Conditioned Reflexes. Oxford, England: Oxford University Press, 1927.Google Scholar
  33. (33).
    Schachter MD, Calcgnetti DJ: Trends in place preference conditioning with a cross-indexed bibliography, 1957–1991.Neuroscience Biobehavioral Review. 1993,17:21–41.CrossRefGoogle Scholar
  34. (34).
    Stewart J, de Wit H: Reinstatement of drug-taking behavior as a method of assessing incentive motivational properties of drugs. In Bozarth MA (ed),Methods of Assessing the Reinforcing Properties of Abused Drugs. New York: Springer-Verlag, 1987, 211–227.Google Scholar
  35. (35).
    Markou A, Weiss F, Gold LH, et al: Animal models of drug craving.Psychopharmacology. 1993,112:163–182.PubMedCrossRefGoogle Scholar
  36. (36).
    Carroll ME, Meisch ME: Increased drug-reinforced behavior due to food deprivation. In Thompson T, Dews PB, Barrett JE (eds),Advances in Behavioral Pharmacology. New York: Academic Press, 1984, 47–88.Google Scholar
  37. (37).
    Gaiardi M, Bartoletti M, Bacchi A, Gubellini C, Babbini M: Increased sensitivity to the stimulus properties of morphine in food-deprived rats.Pharmacology, Biochemistry and Behavior. 1987,26:719–723.CrossRefGoogle Scholar
  38. (38).
    Beck SG, O'Brien JH: Lethal self-administration of morphine by rats.Physiology and Behavior 1980,25:559–564.PubMedCrossRefGoogle Scholar
  39. (39).
    Dib B, Duclaux R: Intracerebroventricular self-injection of morphine in response to pain in rats.Pain. 1982,13:395–406.PubMedCrossRefGoogle Scholar
  40. (40).
    Shaham Y, Alvares K, Nespor SM, Grunberg NE: Effect of stress on oral morphine and fentanyl self-administration in rats.Pharmacology, Biochemistry and Behavior 1992,41:615–619.CrossRefGoogle Scholar
  41. (41).
    Stolerman IP, Kumar R: Preferences for morphine in rats: Validation of an experimental model of dependence.Psychopharmacologia 1970,17:137–150.PubMedCrossRefGoogle Scholar
  42. (42).
    Shaham Y: Immobilization of stress-induced oral opioid self-administration and withdrawal in rats: Role of conditioning factors and the effect of stress on “relapse” to opioid drugs.Psychopharmacology. 1993,111:477–485.PubMedCrossRefGoogle Scholar
  43. (43).
    Shaham Y, Klein LC, Alvares K, Grunberg NE: Effect of stress on oral fentanyl consumption in rats in an operant self-administration paradigm.Pharmacology, Biochemistry and Behavior. 1993,46:315–322.CrossRefGoogle Scholar
  44. (44).
    Shaham Y, Stewart J: Exposure to mild stress enhances the reinforcement efficacy of intravenous heroin self-adminsitration in rats.Psychopharmacology 1994,114:523–527.PubMedCrossRefGoogle Scholar
  45. (45).
    Hodos W: Progressive ratio as a measure of reward strength.Science. 1961,134:943–944.PubMedCrossRefGoogle Scholar
  46. (46).
    Roberts DCS, Bennett SAL: Heroin self-administration in rats under a progressive ratio schedule of reinforcement.Psychopharmacology. 1993,111:215–218.PubMedCrossRefGoogle Scholar
  47. (47).
    Katz RJ, Roth KA, Schmaltz K, Sible M: Interaction of stress and morphine in the rat using a classical conditioning paradigm.Behavioral and Neural Biology. 1980,28:366–371.PubMedCrossRefGoogle Scholar
  48. (48).
    Van der Kooy D: Place conditioning: A simple and effective method for assessing the motivational properties of drugs. In Bozarth MA (ed),Methods of Assessing the Reinforcing Properties of Abused Drugs. New York: Springer-Verlag, 1987, 229–240.Google Scholar
  49. (49).
    Kiyatkin EA, Belye VP: Reinforcing properties of morphine chronically used in aversive life conditions: Place-preference paradigm, long-term changes in behavioral reactivity.International Journal of Neuroscience 1991,57:193–203.PubMedGoogle Scholar
  50. (50).
    Papp M, Lappas S, Muscat R, Willner P: Attenuation of place preference conditioning but not place aversion conditioning by chronic mild stress.Journal of Psychopharmacology 1992,6: 352–356.CrossRefGoogle Scholar
  51. (51).
    Shaham Y, Stewart J: Stress reinstates herein self-administration behavior in drug-free animals: An effect mimicking heroin, not withdrawal.Psychopharmacology. 1995,119:334–341.PubMedCrossRefGoogle Scholar
  52. (52).
    Shaham Y, Stewart J: Characterization of stress- and heroin-primed relapse to heroin-seeking behavior in rats.Society for Neuroscience Abstracts. 1995,21:725.Google Scholar
  53. (53).
    Shaham Y, Stewart J: Effects of opioid and dopamine receptor antagonists on relapse induced by stress and re-exposure to heroin in rats.Psychopharmacology 1996,125:385–391.PubMedCrossRefGoogle Scholar
  54. (54).
    Stewart J: Reinstatement of hereoin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area.Pharmacology, Biochemistry and Behavior. 1984,20:917–923.CrossRefGoogle Scholar
  55. (55).
    Wise RA, Murray A, Bozarth MA: Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats.Psychopharmacology 1990,100:355–360.PubMedCrossRefGoogle Scholar
  56. (56).
    Shaham Y, Rajabi H, Stewart J: Relapse to heroin-seeking under opioid maintenance: The effects of opioid withdrawal, heroin priming, and stress.Journal of Neuroscience. 1996,16:1957–1963.PubMedGoogle Scholar
  57. (57).
    Dib B: A study of intrathecal self-injection of morphine by rats, and the difficulties entailed.Pain, 1985,23:177–185.PubMedCrossRefGoogle Scholar
  58. (58).
    Shaham Y, Kelsey JE, Stewart J: Temporal factors in the effect of restraint stress on morphine-induced behavioral sensitization in the rat.Psychopharmacology 1995,117:102–109.PubMedCrossRefGoogle Scholar
  59. (59).
    Babbini A, Gaiardi M, Bartoletti M: Persistence of chronic morphine effects upon activity in rats 8 months after ceasing the treatment.Neuropharmacology. 1975,14:611–614.PubMedCrossRefGoogle Scholar
  60. (60).
    Wise RA, Bozarth MA: A psychomotor stimulant theory of addiction.Psychological Review. 1987,94:469–492.PubMedCrossRefGoogle Scholar
  61. (61).
    Eikelboom R, Stewart J: Conditioning of drug-induced physiological responses.Psychological Review. 1982,89:507–528.PubMedCrossRefGoogle Scholar
  62. (62).
    Wikler A: Dynamics of drug dependence, implication of a conditioning theory for research and treatment.Archives of General Psychiatry 1973,28:611–616.PubMedGoogle Scholar
  63. (63).
    Childress AR, Mclellan TA, O'Brien CP: Role for conditioning factors in the development of drug dependence.Psychiatric Clinics of North America 1986,9:413–425.PubMedGoogle Scholar
  64. (64).
    Whitehead CC: Methadone pseudowithdrawal syndrome: Paradigm for a psychopharmacological model of opiate addiction.Psychosomatic Medicine. 1974,36:189–198.PubMedGoogle Scholar
  65. (65).
    Poulos CW, Hinson R, Siegel S: The role of Pavlovian conditioning in drug tolerance and dependence: Implications for treatment.Addictive Behaviors. 1981,6:205–211.PubMedCrossRefGoogle Scholar
  66. (66).
    Olds J, Milner PM: Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain.Journal of Comparative Physiological Psychology. 1954,47:419–427.CrossRefGoogle Scholar
  67. (67).
    McGregor IS, Atrens DM: Stressor-like effects of FG-7142 on medial prefrontal cortex self-stimulation.Brain Research. 1990,516:170–174.PubMedCrossRefGoogle Scholar
  68. (68).
    Katz RJ, Roth KA: Tail pinch induced stress-arousal facilitates brain stimulation reward.Physiology and Behavior. 1979,22:193–194.PubMedCrossRefGoogle Scholar
  69. (69).
    Moreau JL, Jenck F, Martin JR, Haefely WE: Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmental self-stimulation behavior in rats.European Journal of Neuropsychopharmacology 1992,2: 43–49.CrossRefGoogle Scholar
  70. (70).
    Zacharko RM, Bowers WJ, kelley MS, Anisman H: Prevention of stressor-induced disturbances of self-stimulation by desmethylimipramine.Brain Research. 1984,321:175–179.PubMedCrossRefGoogle Scholar
  71. (71).
    Zacharko RM, Anisman H: Stress-induced anhedonia in the mesocorticolimbic system.Neuroscience Biobehavioral Review. 1991,15:391–405.CrossRefGoogle Scholar
  72. (72).
    Gardner EL: Brain reward mechanisms In Lowinson JW, Luiz P, Millman RB, Langard JG (eds),Substance Abuse: A Comprehensive Textbook. Baltimore, MD: Williams & Wilkins, 1992, 70–99.Google Scholar
  73. (73).
    Glavin GB: Stress and brain noradrenaline: A review.Brain Research Reviews. 1985,9:233–243.Google Scholar
  74. (74).
    Redmond DEJ, Huang YH: Locus coeruleus and anxiety.Life Sciences. 1979,25:2149–2162.PubMedCrossRefGoogle Scholar
  75. (75).
    Redmond DEJ, Krystal JH: Multiple mechanisms of withdrawal from opioid drugs.Annual Review of Neuroscience. 1984,7:443–478.PubMedCrossRefGoogle Scholar
  76. (76).
    Deutch AY, Roth RH: The determinants of stress-induced activation of the prefrontal cortical dopamine system.Progress in Brain Research. 1990,85:367–403.PubMedCrossRefGoogle Scholar
  77. (77).
    Kurumaji A, Takashima M, Shibuya H: Cold and immobilization of stress-induced changes in pain responsiveness and brain metenkephalin-like immunoreactivity in the rat.Peptides 1987,8: 355–359.PubMedCrossRefGoogle Scholar
  78. (78).
    Przewlocki R, Majeed NH, Wedzony KA, Przewlocka B: The effect of stress on opioid peptide systems in the rat nucleus accumbens. In Van Loon GR, Kvetnansky R, McCarty R, Axelrod J (eds),Stress: Neurochemical and Humoral Mechanisms. New York: Gordon & Breach Science Publishers S.A., 1989, 155–161.Google Scholar
  79. (79).
    Koob GF, Bloom FE: Cellular and molecular mechanisms of drug dependence.Science. 1988,242:715–723.PubMedCrossRefGoogle Scholar
  80. (80).
    Robinson TE, Berridge KC: The neural basis of drug craving: An incentive-sensitization theory of addiction.Brain Research Reviews. 1993,18:247–291.PubMedCrossRefGoogle Scholar
  81. (81).
    Stewart J: Neurobiology of conditioning to drug abuse.Annals of the New York Academy of Sciences. 1992,654:335–346.PubMedCrossRefGoogle Scholar
  82. (82).
    Miller R, Wickens JR, Beninger RJ: Dopamine D-1 and D-2 receptors in relation to reward and performance: A case of the D-1 receptor as a primary site of the therapeutic action of neuroleptic drugs.Progress in Neurobiology 1990,34:143–183.PubMedCrossRefGoogle Scholar
  83. (83).
    Witkin J: Pharmacotherpay of cocaine abuse: Preclinical development.Neuroscience Biobehavioral Review. 1994,1:121–142.CrossRefGoogle Scholar
  84. (84).
    Sanger DJ, Blackman DE: Rate-dependent effects of drugs: A review of the literature.Pharmacology, Biochemistry and Behavior. 1976,4:73–83.CrossRefGoogle Scholar
  85. (85).
    Bhargava HN: Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior.Pharmacological Review. 1994,46:293–324.Google Scholar

Copyright information

© The Society of Behavioral Medicine 1996

Authors and Affiliations

  • Yavin Shaham
    • 1
  1. 1.Biobehavioral Research DepartmentAddiction Research FoundationTorontoCanada

Personalised recommendations